Funding for Lung Cancer Research

Lung cancer is the most deadly cause of cancer death and the second most common form of cancer in both men and women.  Yet despite this, the federal response to lung cancer research funding has not yet matched the urgent need presented by the disease.

Funding for lung cancer research is of paramount importance, not only because of the number of Americans it affects, but also because it is still difficult to detect in its early stages.  Presently, only 15 percent of lung cancers are diagnosed in an early stage.  By the time symptoms are recognized, the cancer has often progressed.  For that and for other reasons, the lung cancer five-year survival rate (15.6 percent) is lower than many other leading cancers. 

In February of 2010, the American Lung Association and 16 of our partner organizations sent a letter to the chairmen and ranking members of the appropriations committees in the U.S. House of Representatives and U.S. Senate, asking for a "significant increase in funding for lung cancer research, treatment, prevention and patient services."  The letter goes on to state that "research for this deadly disease must be expanded so that surviving lung cancer becomes the norm instead of the exception."  A copy of the letter sent to can be found here.

Early detection of lung cancer can increase survival rates. Call the Lung Helpline at 1-800-LUNGUSA or talk to your doctor about lung cancer screening.